# Tresiba

NDC: 0169-2550
Generic name: insulin degludec
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20150925

FDA application: BLA203314

## Active ingredients

- INSULIN DEGLUDEC: 200 U/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-2550"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-2550
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=456c5e87-3dfd-46fa-8ac0-c6128d4c97c6